Clinical immunity after neonatal rotavirus infection. A prospective longitudinal study in young children
- PMID: 6304516
- DOI: 10.1056/NEJM198307143090203
Clinical immunity after neonatal rotavirus infection. A prospective longitudinal study in young children
Abstract
To determine whether rotavirus infection in newborn babies conferred immunity to postneonatal rotavirus infection, we studied 81 babies at birth and kept them under clinical and serologic study for three years. During the first 14 days of life, 44 of the infants excreted rotavirus, and 37 did not. Fifty-five per cent of those with neonatal infection and 54 per cent of those without it had rotavirus infection during the next three years. Symptoms associated with postneonatal rotavirus infection were significantly less frequent and less severe in the infants who had had neonatal infection (P = 0.003) than in those who had not. Thirty-eight per cent of the former group (9 of 24 infants) had symptoms of mild (3 infants) or moderate (6) severity during the first postneonatal infection. In contrast, 85 per cent of the latter group (17 of 20 infants) had mild (3), moderate (6), or severe (8) symptoms. We conclude that neonatal rotavirus infection does not confer immunity against reinfection but does protect against the development of clinically severe disease during reinfection.
Similar articles
-
Rotavirus infection in adults. Results of a prospective family study.N Engl J Med. 1979 Aug 9;301(6):303-6. doi: 10.1056/NEJM197908093010604. N Engl J Med. 1979. PMID: 221816
-
[Seroepidemiology of human rotaviruses in a community of the Avellaneda district, Province of Buenos Aires].Rev Argent Microbiol. 1990 Oct-Dec;22(4):182-91. Rev Argent Microbiol. 1990. PMID: 1966501 Spanish.
-
Serum antibody as a marker of protection against natural rotavirus infection and disease.J Infect Dis. 2000 Dec;182(6):1602-9. doi: 10.1086/317619. Epub 2000 Oct 23. J Infect Dis. 2000. PMID: 11069230
-
Protective effects of natural rotavirus infection.Pediatr Infect Dis J. 2009 Mar;28(3 Suppl):S54-6. doi: 10.1097/INF.0b013e3181967c03. Pediatr Infect Dis J. 2009. PMID: 19252424 Review.
-
[Rotaviruses in human and veterinary medicine].Sante. 1997 May-Jun;7(3):195-9. Sante. 1997. PMID: 9296811 Review. French.
Cited by
-
Does a monovalent inactivated human rotavirus vaccine induce heterotypic immunity? Evidence from animal studies.Hum Vaccin Immunother. 2013 Aug;9(8):1634-7. doi: 10.4161/hv.24958. Epub 2013 Jun 6. Hum Vaccin Immunother. 2013. PMID: 23744507 Free PMC article.
-
Disease caused by rotavirus infection.Open Virol J. 2014 Dec 11;8:14-9. doi: 10.2174/1874357901408010014. eCollection 2014. Open Virol J. 2014. PMID: 25553142 Free PMC article.
-
Importance of rotavirus and adenovirus types 40 and 41 in acute gastroenteritis in Korean children.J Clin Microbiol. 1990 Oct;28(10):2279-84. doi: 10.1128/jcm.28.10.2279-2284.1990. J Clin Microbiol. 1990. PMID: 2172286 Free PMC article.
-
Mice develop effective but delayed protective immune responses when immunized as neonates either intranasally with nonliving VP6/LT(R192G) or orally with live rhesus rotavirus vaccine candidates.J Virol. 2006 May;80(10):4949-61. doi: 10.1128/JVI.80.10.4949-4961.2006. J Virol. 2006. PMID: 16641286 Free PMC article.
-
Human Neonatal Rotavirus Vaccine (RV3-BB) Produces Vaccine Take Irrespective of Histo-Blood Group Antigen Status.J Infect Dis. 2020 Mar 16;221(7):1070-1078. doi: 10.1093/infdis/jiz333. J Infect Dis. 2020. PMID: 31763671 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical